Orchid Pharmed Company

Orchid Pharmed is a leading pharmaceutical company based in Iran that specializes in the clinical development, marketing, and distribution of high-tech biopharmaceuticals and biosimilars. The company operates as a strategic commercialization partner for major regional manufacturers, including CinnaGen and AryoGen Pharmed, focusing on complex therapeutic areas such as oncology, neurology, and autoimmune diseases. Beyond its commercial activities, Orchid Pharmed functions as a contract research organization (CRO), managing large-scale Phase III and IV clinical trials to ensure market access and regulatory compliance. Its extensive portfolio includes biosimilar versions of global blockbuster drugs like rituximab, trastuzumab, and etanercept. By bridging the gap between manufacturing and patient care, the company plays a critical role in providing affordable, high-quality biological treatments across the Middle East and North Africa (MENA) region.